We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-10.29%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$501M
AUM Growth
+$25.6M
Cap. Flow
+$93.2M
Cap. Flow %
18.6%
Top 10 Hldgs %
66.14%
Holding
135
New
29
Increased
35
Reduced
10
Closed
61

Top Buys

Rank Stock Value
1
ICUI icon
ICU Medical
ICUI
+$5.87M
2
INSP icon
Inspire Medical Systems
INSP
+$5.07M
3
GH icon
Guardant Health
GH
+$4.07M
4
SIBN icon
SI-BONE Inc
SIBN
+$4.06M
5
NSTG
NanoString Technologies, Inc.
NSTG
+$3.8M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$8.34M
2
MDT icon
Medtronic
MDT
+$7.57M
3
AZTA icon
Azenta
AZTA
+$5.7M
4
CNC icon
Centene
CNC
+$5.49M
5
ZBH icon
Zimmer Biomet
ZBH
+$5.26M

Sector Composition

Rank Sector Weight
1 Healthcare 28.11%
2 Industrials 0.17%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GH icon
26
Guardant Health
GH
$22.4B
$4.15M 0.83%
+110,363
New +$4.07M
KIDS icon
27
OrthoPediatrics
KIDS
$608M
$4.08M 0.81%
116,831
+15,997
+16% +$507K
AMGN icon
28
Amgen
AMGN
$226B
$3.89M 0.78%
20,000
-10,373
-34% -$2.02M
TNDM icon
29
Tandem Diabetes Care
TNDM
$1.59B
$3.68M 0.73%
96,914
+20,981
+28% +$741K
LIVN icon
30
LivaNova
LIVN
$4.21B
$3.66M 0.73%
40,000
-30,871
-44% -$3.32M
INCY icon
31
Incyte
INCY
$24.6B
$3.51M 0.7%
+55,207
New +$3.58M
NVRO
32
PUT
DELISTED
NEVRO CORP.
NVRO
$3.5M 0.7%
90,000
+30,000
+50% +$1.33M
ALXN
33
DELISTED
Alexion Pharmaceuticals
ALXN
$3.33M 0.67%
34,237
+19,113
+126% +$2.26M
INSP icon
34
CALL
Inspire Medical Systems
INSP
$1.73B
$3.17M 0.63%
+75,000
New +$3.19M
VAPO
35
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$2.98M 0.6%
+18,694
New +$2.7M
ATRC icon
36
AtriCure
ATRC
$2.12B
$2.75M 0.55%
90,030
+22,360
+33% +$697K
AGN
37
DELISTED
Allergan plc
AGN
$2.67M 0.53%
+20,000
New +$3.28M
OFIX icon
38
CALL
Orthofix Medical
OFIX
$418M
$2.63M 0.52%
+50,000
New +$2.84M
IMGN
39
CALL
DELISTED
Immunogen Inc
IMGN
$2.37M 0.47%
493,400
+293,400
+147% +$1.78M
BDSI
40
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$2.31M 0.46%
+622,922
New +$2.19M
EXEL icon
41
CALL
Exelixis
EXEL
$13.1B
$2.18M 0.43%
110,700
+10,700
+11% +$191K
GBT
42
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.05M 0.41%
+50,000
New +$1.87M
CHRS icon
43
Coherus Oncology
CHRS
$192M
$1.91M 0.38%
+211,071
New +$2.44M
MDRX
44
PUT
DELISTED
Veradigm Inc. Common Stock
MDRX
$1.87M 0.37%
+194,400
New +$2.17M
ZGNX
45
DELISTED
Zogenix, Inc.
ZGNX
$1.78M 0.36%
48,887
+4,169
+9% +$171K
EXEL icon
46
Exelixis
EXEL
$13.1B
$1.69M 0.34%
+86,055
New +$1.53M
VRAY
47
DELISTED
ViewRay, Inc.
VRAY
$1.68M 0.34%
276,805
-344,034
-55% -$2.58M
OTIC
48
DELISTED
Otonomy, Inc.
OTIC
$1.66M 0.33%
896,387
+608,730
+212% +$1.44M
AVNS
49
DELISTED
Avanos Medical
AVNS
$1.46M 0.29%
32,675
-7,885
-19% -$413K
PRQR icon
50
ProQR Therapeutics
PRQR
$255M
$1.21M 0.24%
76,827
+20,024
+35% +$368K
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return

Pura Vida Investments's Q4 2018 Portfolio in Review

As of Q4 2018, Pura Vida Investments held 135 positions worth $501M, up 5.4% from $475M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Pura Vida Investments deployed $93.2M of net new capital in Q4 2018, opening 29 new positions and adding to 35 existing holdings. Its largest new stake was Guardant Health: 110,363 shares worth $4.15M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 35% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Boston Scientific, an estimated $8.34M trimmed.

  • Pura Vida Investments's largest Q4 2018 buy was Guardant Health: 110,363 shares worth $4.15M.
  • Pura Vida Investments added most to ICU Medical in Q4 2018, an estimated $5.87M increase.
  • Pura Vida Investments's biggest Q4 2018 reduction was Boston Scientific, cutting an estimated $8.34M.
  • Pura Vida Investments fully exited Medtronic in Q4 2018, selling an estimated $7.57M.
  • Pura Vida Investments's ten largest holdings make up 66% of its $501M portfolio in Q4 2018.
  • Pura Vida Investments opened 29 new positions and closed 61 in Q4 2018.
  • Pura Vida Investments's portfolio value rose 5.4% quarter-over-quarter to $501M.

Based on Pura Vida Investments's 13F filing for Q4 2018, filed 14 Feb 2019.